Table 2.
Univariate and multivariate analysis of potential prognostic factors affecting overall survival.
| Univariate analysis | Multivariate model | |||||
|---|---|---|---|---|---|---|
| No. of patients | No. of events | P | No. of patients | HR | P | |
| Gender | ||||||
| Male | 51 | 26 | ||||
| Female | 29 | 16 | 0.453 | |||
|
| ||||||
| PS | ||||||
| 0 | 54 | 26 | 45 | 1 | ||
| 1–3 | 26 | 16 | 0.207 | 24 | 1.2 | 0.627 |
|
| ||||||
| Concomitant disease | ||||||
| No | 45 | 23 | ||||
| Yes | 32 | 19 | 0.353 | |||
|
| ||||||
| Site of primary tumour | ||||||
| Small intestine | 21 | 10 | ||||
| Other | 59 | 32 | 0.213 | |||
|
| ||||||
| Serum sodium | ||||||
| Normal | 55 | 22 | 55 | 1 | ||
| Low | 14 | 11 | <0.01 | 14 | 0.3 | 0.04 |
|
| ||||||
| Serum LDH | ||||||
| Normal | 44 | 21 | ||||
| Low | 29 | 16 | 0.846 | |||
|
| ||||||
| Serum Hb | ||||||
| Normal | 21 | 8 | 20 | 1 | ||
| Low | 52 | 29 | 0.099 | 49 | 0.7 | 0.285 |
|
| ||||||
| Neutrophil count | ||||||
| Normal | 57 | 29 | ||||
| High | 16 | 8 | 0.745 | |||